News
- 2025.09.11NEWS RELEASEBreaking the Black Box of EV Therapeutics: EXORPHIA’s CMC Strategy to Be Showcased at an International Summit
-
2025.08.20NEWS RELEASEEXORPHIA and ROHTO Pharmaceutical Enter into Strategic Alliance to Advance Extracellular Vesicle Production Technology
Collaboration combines complementary strengths in regenerative medicine - 2025.08.19NEWS RELEASEMicroRNA-4516 in EXORPHIA’s MSC-EVs Shown to Suppress Pulmonary Fibrosis – Findings Published in International Journal
- 2024.05.23NEWS RELEASEEXORPHIA partners with Kyoritsu Holdings and Kyoritsu Seiyaku to jointly develop exosome-based therapeutics for pets
- 2024.05.23NEWS RELEASEEXORPHIA Receives Positive Feedback from FDA on Pre-IND Meeting for EXP01 Phase 1/2 Clinical Trial in ARDS Patients